ERY-TAB - 21695-457-15 - (erythromycin)

Alphabetical Index


Drug Information of ERY-TAB

Product NDC: 21695-457
Proprietary Name: ERY-TAB
Non Proprietary Name: erythromycin
Active Ingredient(s): 333    mg/1 & nbsp;   erythromycin
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of ERY-TAB

Product NDC: 21695-457
Labeler Name: Rebel Distributors Corp
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA061621
Marketing Category: ANDA
Start Marketing Date: 19720711

Package Information of ERY-TAB

Package NDC: 21695-457-15
Package Description: 15 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-457-15)

NDC Information of ERY-TAB

NDC Code 21695-457-15
Proprietary Name ERY-TAB
Package Description 15 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-457-15)
Product NDC 21695-457
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name erythromycin
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 19720711
Marketing Category Name ANDA
Labeler Name Rebel Distributors Corp
Substance Name ERYTHROMYCIN
Strength Number 333
Strength Unit mg/1
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]

Complete Information of ERY-TAB


General Information